Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 882,500 shares, an increase of 21.7% from the May 15th total of 724,900 shares. Currently, 5.2% of the shares of the company are […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) – Equities researchers at Wedbush raised their Q2 2023 EPS estimates for shares of Rani Therapeutics in a note issued to investors on Thursday, May 11th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($0.33) per share for the quarter, up from their prior […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited purchased 4,420 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The shares were bought at an average price of $4.46 per share, with a total value of $19,713.20. Following the acquisition, the insider now directly […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited purchased 2,173 shares of the business’s stock in a transaction that occurred on Friday, April 28th. The shares were purchased at an average cost of $4.71 per share, with a total value of $10,234.83. Following the completion of the acquisition, the […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Rating) major shareholder South Cone Investments Limited acquired 2,173 shares of Rani Therapeutics stock in a transaction dated Friday, April 28th. The shares were bought at an average cost of $4.71 per share, with a total value of $10,234.83. Following the transaction, the insider now owns 6,854,674 shares […]